| |
Centre for Policy on Ageing | |
 | |
|
Alzheimer's disease in the UK
— comparative evidence on cost of illness and volume of health services research funding | | Author(s) | Ana Lowin, Martin Knapp, Paul McCrone |
| Journal title | International Journal of Geriatric Psychiatry, vol 16, no 12, December 2001 |
| Pages | pp 1143-1148 |
| Keywords | Dementia ; Costs ; Health services ; Research ; Grant allocation ; Comparison. |
| Annotation | A literature search of cost-of-illness studies was conducted and major funders of research were contacted, the aim being to review the economic cost of Alzheimer's disease (AD) and to make comparisons with cancer, stroke and heart disease. The direct costs of AD were estimated to be between £7.06 billion and £14.93 billion, which was substantially greater than for stroke (£3.2 billion), heart disease (£4.05 billion), and cancer (£1.6 billion, excluding informal care costs). Research expenditure on AD was 57% of that on stroke, 10% of that on heart disease, and 3% of that on cancer. As AD imposes a high economic burden, the authors recommend further discussion of the distribution of public funding for research into this disease. (RH). |
| Accession Number | CPA-020118205 A |
| Classmark | EA: WC: L: 3A: QCG: 48 |
Data © Centre for Policy on Ageing |
|
| ...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|